Keywords: 3،4-دیامینوپیریدین; 3,4-Diaminopyridine; Treatment; Anti-acetylcholine receptor antibody; Myasthenia gravis; Lambert-Eaton myasthenic syndrome;
مقالات ISI 3،4-دیامینوپیریدین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: 3،4-دیامینوپیریدین; Botulinum neurotoxin; 3,4-Diaminopyridine; Isometric muscle contractions; Endplate recordings; Neurotransmission; Release probability; BoNT; botulinum neurotoxin; DAP; 3,4-diaminopyridine; HC; heavy chain; LC; light chain; NMJ; neuromuscular junction; EPP
Keywords: 3،4-دیامینوپیریدین; Multiple sclerosis; Fatigue; Amantadine; Modafinil; Aspirin; Acetyl-l-carnitine; Pemoline; 3,4-Diaminopyridine; 4-Aminopyridine; Pharmacological treatments;
Keywords: 3،4-دیامینوپیریدین; Aged; Bassoon; Neuromuscular junction; Laminin; Voltage-gated calcium channels; 3,4-diaminopyridine; (3,4-DAP); Acetylcholine; (ACh); acetylcholine receptor; (AChR); adenosine monophosphate-activated protein kinase; (AMPK); basal cell adhesion molecule/Lu
Keywords: 3،4-دیامینوپیریدین; amifampridine; food effects; pharmacokinetics; 3,4-diaminopyridine; 3,4-DAP; Lambert-Eaton Myasthenic Syndrome;
Metal-involved theranostics: An emerging strategy for fighting Alzheimer's disease
Keywords: 3،4-دیامینوپیریدین; 3,4Apy; 3,4-diaminopyridine; 4Apy; 4-aminopyridine; AChE; acetylcholinesterase; AD; Alzheimer's disease; AFM; atomic force microscopy; APP; amyloid precursor protein; Aβ; amyloid-β peptide; BBB; blood brain barrier; bpy; 2,2-bipyridine; BSA; bovine se
Lambert-Eaton Myasthenic Syndrome
Keywords: 3،4-دیامینوپیریدین; Lambert-Eaton myasthenic syndrome; Neuromuscular transmission disorder; Paraneoplastic syndrome; P/Q-type voltage-gated calcium channels; 3,4-Diaminopyridine;
Phenotypic heterogeneity in two large Roma families with a congenital myasthenic syndrome due to CHRNE 1267delG mutation. A long-term follow-up
Keywords: 3،4-دیامینوپیریدین; CHRNE; Acetylcholine receptor; Congenital myasthenic syndrome; Congenital myasthenia; Roma gypsies; Neuromuscular junction; Pyridostigmine; 3,4-Diaminopyridine; Founder mutation;
Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations
Keywords: 3،4-دیامینوپیریدین; Rapsyn; Congenital myasthenic syndrome; Congenital myasthenia; Neuromuscular junction; Pyridostigmine; 3,4-diaminopyridine;
Myasthenia gravis with presynaptic neurophysiological signs: Two case reports and literature review
Keywords: 3،4-دیامینوپیریدین; Myasthenia gravis; Lambert-Eaton myasthenic syndrome; Presynaptic neurophysiological pattern; Cholinesterase inhibitors; 3,4-Diaminopyridine;
Lambert-Eaton myasthenic syndrome in a 13-year-old girl with Xp11.22-p11.23 duplication
Keywords: 3،4-دیامینوپیریدین; Lambert-Eaton myasthenic syndrome; Chromosome Xp11.23-P11.22 duplication syndrome; Genetic predisposition to autoimmune diseases; Forkhead box P3; Wiskott-Aldrich syndrome gene; CMAP; compound muscle action potentials; 3,4-DAP; 3,4-diaminopyridine; EM
3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis
Keywords: 3،4-دیامینوپیریدین; Myasthenia gravis; MuSK; 3,4-Diaminopyridine;
Reversal of BoNT/A-mediated inhibition of muscle paralysis by 3,4-diaminopyridine and roscovitine in mouse phrenic nerve-hemidiaphragm preparations
Keywords: 3،4-دیامینوپیریدین; Botulinum neurotoxin; 3,4-Diaminopyridine; Roscovitine; Acetylcholine; Mouse; Diaphragm muscle; Aminopyridine; Potassium channel blocker; Calcium channel agonist; Bioterrorism
The effect of 3,4-diaminopyridine on the patients with hereditary pure cerebellar ataxia
Keywords: 3،4-دیامینوپیریدین; Spinocerebellar ataxia; Nystagmus; Cerebellum; Potassium channel blockers; 3,4-Diaminopyridine
Quantification of 4-aminopyridine in plasma by capillary electrophoresis with electrokinetic injection
Keywords: 3،4-دیامینوپیریدین; 4-Aminopyridine; 3,4-Diaminopyridine; Plasma; Capillary electrophoresis; Pharmacokinetics; Pharmacodynamics; Electrokinetic injection
Anharmonic vibrational analysis of 3,4-diaminopyridine and 3-aminopyridine by density functional theory calculations
Keywords: 3،4-دیامینوپیریدین; Vibrational spectra; DFT; 3-Aminopyridine; 3,4-Diaminopyridine; Anharmonic; UV spectrum
Spectroscopic and structural elucidation of 3,4-diaminopyridine and its hydrogentartarate salt: Crystal structure of 3,4-diaminopyridinium hydrogentartarate dihydrate
Keywords: 3،4-دیامینوپیریدین; 3,4-Diaminopyridine; Hydrogentartarate salt; Crystal structure; Solid-state linear polarized IR-spectroscopy; UV-; Quantum chemical calculations;
Stability studies of ionised and non-ionised 3,4-diaminopyridine: Hypothesis of degradation pathways and chemical structure of degradation products
Keywords: 3،4-دیامینوپیریدین; 3,4-Diaminopyridine; HPLC–MS; Stress condition; Stability studies; Impurities
The Therapy of Congenital Myasthenic Syndromes
Keywords: 3،4-دیامینوپیریدین; Congenital myasthenic syndromes; acetylcholine receptor; acetylcholinesterase; choline acetyltransferase; rapsyn; Dok-7; MuSK; cholinesterase inhibitors; 3,4-diaminopyridine; quinidine; fluoxetine;
Synthesis and characterisation of unsymmetrical Schiff bases derived from 3,4-diaminopyridine. Crystal and molecular structure of hydrogen-bonded dimers of 3-{[(4-aminopyridin-3-yl)amino]methylene}pentane-2,4-dione
Keywords: 3،4-دیامینوپیریدین; 3,4-Diaminopyridine; Schiff bases; Dimer; X-ray structure; Hydrogen bonding;
Taicatoxin inhibits the calcium-dependent slow motility of mammalian outer hair cells
Keywords: 3،4-دیامینوپیریدین; K+; potassium; Ca2+; calcium; ACh; acetylcholine; EGTA; acetic acid, (ethylenebis(oxyethylenenitrilo)) tetra- and ethylene glycol bis(2-aminoethyl ether)-N,N,Nâ²Nâ²-tetraacetic acid; TEA; tetraethylammonium chloride; 3,4-DAP; 3,4-diaminopyridine; Taicat